Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hiromichi Otaka
Institution:
Institute of Science Tokyo
Observed institutions:
Tokyo Medical and Dental University,
Novartis (Japan),
Institute of Science Tokyo
ORCID:
0000-0003-4577-6235
Observed ORCID:
0000-0003-4577-6235
OpenAlex ID:
A5059224895
Epidemiology of progressive multifocal leukoencephalopathy in Japan and effectiveness of mefloquine: A retrospective analysis of a nationwide inpatient database
2023
·
Hiromichi Otaka
, Shinobu Imai
, et al.
·
Journal of the Neurological Sciences
·
7
Systematic review and network meta‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis
2022
·
Christopher Drudge
, Melody Zhao
, et al.
·
Clinical and Experimental Neuroimmunology
·
3
PDF
A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data
2022
·
Izumi Kawachi
, Hiromichi Otaka
, et al.
·
Neurology and Therapy
·
3
PDF
Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis
2022
·
Izumi Kawachi
, Hiromichi Otaka
, et al.
·
Neurology and Therapy
·
2
PDF
Influence of inpatient rehabilitation after crisis in patients with myasthenia gravis: A retrospective cohort study using a nationwide administrative database in Japan
2022
·
Hiromichi Otaka
, Shinobu Imai
, et al.
·
Journal of the Neurological Sciences
·
2
Hospital volume impact on multiple sclerosis outcomes: a retrospective cohort study using a nationwide administrative database in Japan
2025
·
Hiromichi Otaka
, Shinobu Imai
, et al.
·
Multiple Sclerosis and Related Disorders
·
1
Show more works
View as search
Works count:
6
Citation count:
18
H-index:
3
I10-index:
Year
Topic
Type